🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial studies the side effects and best dose of alisertib and ...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2013-07-17
Trial ID
NCT01897012
Treatments Being Tested
The goal of this clinical trial is to determine how well people tolerate tr...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-30
Trial ID
NCT07465757
This phase I trial studies the side effects and best dose of alisertib when...
Status
Completed
Location
Sidney Kimmel Cancer Center at Thomas Jefferson University
Start Date
2015-01-30
Trial ID
NCT02186509
This is a two-arm, randomized, double-blind, placebo-controlled, multicente...
Status
Completed
Location
Multiple Locations
Start Date
2014-05-12
Trial ID
NCT02038647
Treatments Being Tested
This is an open-label, multicenter study with a nonrandomized Phase 1 porti...
Status
Completed
Location
Multiple Locations
Start Date
2010-04-16
Trial ID
NCT01091428
Treatments Being Tested
Background: Progress in developing new effective therapies in advanced and...
Status
Completed
Location
Fondazione IRCCS Istituto Nazionale dei Tumori
Start Date
2014-08-28
Trial ID
NCT02109328
Treatments Being Tested
This phase I trial studies the side effects and the best dose of alisertib ...
Status
Completed
Location
UC Davis Comprehensive Cancer Center
Start Date
2013-08-09
Trial ID
NCT01924260
Treatments Being Tested
RATIONALE: Aurora A kinase inhibitor MLN8237 and bortezomib may stop the gr...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2010-02
Trial ID
NCT01034553
Treatments Being Tested
The purpose of this study is to evaluate the anti-tumour activity of aliser...
Status
Completed
Location
Summit Medical Group
Start Date
2009-03-23
Trial ID
NCT00853307
Treatments Being Tested
This study will evaluate the initial safety and effectiveness of an investi...
Status
Completed
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2012-02
Trial ID
NCT01540682
Treatments Being Tested